Biohaven and Pfizer complete collaboration transaction for commercialization of rimegepant & zavegepant outside US
By, Admin1 min read
Share
Biohaven Pharmaceutical Holding Company Ltd. and Pfizer Inc. announced that the parties have completed the collaboration transaction between the two companies. The transaction agreements, including Pfizer
Found this useful? Share it with your team.
Newsletter
Stay ahead with Clival insights
Subscribe to get the latest updates, data releases and industry information — straight to your inbox.